01 1Synthon Pharmaceuticals
01 1IXAZOMIB CITRATE
01 1Netherlands
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-03-04
Pay. Date : 2025-01-24
DMF Number : 41022
Submission : 2025-01-30
Status : Active
Type : II
20
Synthon Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IXAZOMIB CITRATE, with a corresponding US DMF Number 41022.
Remarkably, this DMF maintains an Active status since its submission on January 30, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 04, 2025, and payment made on January 24, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
